Extrawell Pharmaceutical Holdings Limited - Net Worth and Insider Trading

Extrawell Pharmaceutical Holdings Limited Net Worth

The estimated net worth of Extrawell Pharmaceutical Holdings Limited is at least $61 Million dollars as of 2024-09-26. Extrawell Pharmaceutical Holdings Limited is the of Innovative Pharmaceutical Biotech Ltd and owns about 286,000,000 shares of Innovative Pharmaceutical Biotech Ltd (HKSE:00399) stock worth over $61 Million. Details can be seen in Extrawell Pharmaceutical Holdings Limited's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Extrawell Pharmaceutical Holdings Limited has not made any transactions after 2024-01-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Extrawell Pharmaceutical Holdings Limited

Extrawell Pharmaceutical Holdings Limited Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Extrawell Pharmaceutical Holdings Limited owns 1 companies in total, including Innovative Pharmaceutical Biotech Ltd (HKSE:00399) .

Click here to see the complete history of Extrawell Pharmaceutical Holdings Limited’s form 4 insider trades.

Insider Ownership Summary of Extrawell Pharmaceutical Holdings Limited

Ticker	Comapny	Transaction Date	Type of Owner
HKSE:00399	Innovative Pharmaceutical Biotech Ltd	2024-01-10

Extrawell Pharmaceutical Holdings Limited Latest Holdings Summary

Extrawell Pharmaceutical Holdings Limited currently owns a total of 1 stock. Extrawell Pharmaceutical Holdings Limited owns 286,000,000 shares of Innovative Pharmaceutical Biotech Ltd (HKSE:00399) as of January 10, 2024, with a value of $61 Million.

Latest Holdings of Extrawell Pharmaceutical Holdings Limited

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:00399	Innovative Pharmaceutical Biotech Ltd	2024-01-10	286,000,000	0.21	60,632,000

Holding Weightings of Extrawell Pharmaceutical Holdings Limited

Extrawell Pharmaceutical Holdings Limited Form 4 Trading Tracker

According to the SEC Form 4 filings, Extrawell Pharmaceutical Holdings Limited has made a total of 3 transactions in Innovative Pharmaceutical Biotech Ltd (HKSE:00399) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Innovative Pharmaceutical Biotech Ltd is the sale of 0 shares on January 10, 2024, which brought Extrawell Pharmaceutical Holdings Limited around $0.

Insider Trading History of Extrawell Pharmaceutical Holdings Limited

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Extrawell Pharmaceutical Holdings Limited Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Extrawell Pharmaceutical Holdings Limited Ownership Network

Ownership Network List of Extrawell Pharmaceutical Holdings Limited

No Data

Ownership Network Relation of Extrawell Pharmaceutical Holdings Limited

Extrawell Pharmaceutical Holdings Limited Owned Company Details

What does Innovative Pharmaceutical Biotech Ltd do?

Who are the key executives at Innovative Pharmaceutical Biotech Ltd?

Extrawell Pharmaceutical Holdings Limited is the of Innovative Pharmaceutical Biotech Ltd. Other key executives at Innovative Pharmaceutical Biotech Ltd include 2101 Beneficial owner Mao Yumin , 2101 Beneficial owner Mao YuMin , and 2101 Beneficial owner Chau Yiu Ting .

Innovative Pharmaceutical Biotech Ltd (HKSE:00399) Insider Trades Summary

Over the past 18 months, Extrawell Pharmaceutical Holdings Limited made 3 insider transaction in Innovative Pharmaceutical Biotech Ltd (HKSE:00399) with a net sale of 0. Other recent insider transactions involving Innovative Pharmaceutical Biotech Ltd (HKSE:00399) include a net sale of 100,000,000 shares made by Mao YuMin , a net purchase of 100,000,000 shares made by Chau Yiu Ting , and a net sale of 20,000,000 shares made by Mao Yumin .

In summary, during the past 3 months, insiders sold 0 shares of Innovative Pharmaceutical Biotech Ltd (HKSE:00399) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 120,000,000 shares of Innovative Pharmaceutical Biotech Ltd (HKSE:00399) were sold and 100,000,000 shares were bought by its insiders, resulting in a net sale of 20,000,000 shares.

Innovative Pharmaceutical Biotech Ltd (HKSE:00399)'s detailed insider trading history can be found in Insider Trading Tracker table.

Innovative Pharmaceutical Biotech Ltd Insider Transactions

No Available Data

Extrawell Pharmaceutical Holdings Limited Mailing Address

Above is the net worth, insider trading, and ownership report for Extrawell Pharmaceutical Holdings Limited. Currently GuruFocus does not have mailing address information for Extrawell Pharmaceutical Holdings Limited.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.